|
|
See Category: Diseases of the digestive system
See Header: Cholangitis
ICD-10 (CM) Code and Descriptor
|
K83.01 |
Primary sclerosing cholangitis
|
K8301 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 43.97%
|
22.14%
|
12.07%
|
7.00%
|
4.88%
|
2.90%
|
2.02%
|
1.43%
|
0.99%
|
0.70%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for K83.01*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,563
|
1,570
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,379
|
1,380
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,120
|
1,120
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,053
|
1,057
|
|
85610
|
PROTHROMBIN TIME |
1,023
|
1,025
|
|
74183
|
MRI ABD W/O CNTR FLWD CNTR |
647
|
647
|
|
86301
|
IMMUNOASSAY TUMOR CA 19-9 |
630
|
630
|
|
80076
|
HEPATIC FUNCTION PANEL |
486
|
486
|
|
85027
|
COMPLETE CBC AUTOMATED |
410
|
410
|
|
82105
|
ALPHA-FETOPROTEIN SERUM |
402
|
402
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
354
|
11,009
|
|
C1769
|
GUIDE WIRE |
289
|
401
|
|
82248
|
BILIRUBIN DIRECT |
270
|
270
|
|
G1004
|
CDSM NDSC |
267
|
274
|
|
J2405
|
ONDANSETRON HCL INJECTION |
242
|
1,038
|
|
J3010
|
FENTANYL CITRATE INJECTION |
232
|
314
|
|
82977
|
ASSAY OF GGT |
227
|
227
|
|
80048
|
METABOLIC PANEL TOTAL CA |
222
|
222
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
215
|
216
|
|
A9585
|
GADOBUTROL INJECTION |
193
|
13,695
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
K83.01 related to the following DRG Codes:
444-446
791
793
|
